This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout

“General requires a wonderful healthy requirement to ensure it is for each of the companies, it will be worth their value,” Bekker said. “We all hope for the governments [across sub-Saharan Africa] The extensive product is writing to the future, but the realities rely on the intermediate and donor financing. Even in South Africa, which is 80 percent of the response to good GDP and HIV, South Africa in South Africa in South Africa, South Africa for 6 million people. I would like to take several years to be able to mobilize money for Lenacapavir. “

The visible Pepfar is now worried about the treatment, prevention of existing patients, the prevention of the doctor-scientist in South Africa, the ratio of infection will begin to grow more, African continent and outside the people will affect health.

Speaking at Kigali last week’s NCD Union Forum, Chandiwana explained that the results of the new infection are not only related to HIV. Research, even hypertension, obesity and type diabetes, which are even managed by long-term HIV infections, even hypertension, obesity and type diabetes are higher in the development of metabolic conditions that are already raised in subabolic conditions sub-Saharan Africa. “HIV herself also violates your metabolism, as many as antiretroviral,” said Chandiwana. “We see the same chronic diseases in people in the general population, but in the previous and accelerated way HIV.”

Therefore, a new generation has a need for HIV treatment and a concept was the use of future combinations for those who are already related to the virus. Along with all the way easier to lighten a number of metabolic side effects, it was hoped that this could lead to treatment protocols that do not require daily medications.

“Becker says:” Various opinions were involved, “he said.” Can you combine Bimonthly Cabotegravir with a six-month-old non-monthly lenacapavir injection? [as a form of viral suppression]So you will only come six times a year for treatment and would all be injected? Works have a weekly antiretroviral pill and can you combine it with a six-month enjececle? It can always be released for people because they always say that it should take a daily medicine. “

Beker’s expected to be funded by US resources are still in doubt. “This is not only pepfar; We are concerned about restricting restrictions on other research financing such as national health institutions,” he says. “It will be more difficult to innovate and move forward.”

According to NGURE, other donors can be supported by the global fund in Lenacapavir that Becker said that the prevention of Prevention and research of HIVs and maybe research new options to rescue sources from the Sources of Scandinavia. Japan and Australia. At the same time, he thinks that the events of the last month should be able to finance more preventive efforts in African countries.

“Somehow it is necessary to step into Africa and contribute to the fight,” he says. “I think this is a great question. We can contribute to this continent through countries that cannot cover a large amount of research and development, but need in the future.”

At the same time, without the same sources from the United States, it is afraid of the loss of unique opportunity provided by Lenacapavir.

“It is incredible that this happened as we have progress,” he says. “I think this intends to return our many years, and as a result, the consequences will be more likely to expend the health. Because if we can manage this epidemic faster, it will make the planet a long time and save his life for a long time.”